methyl (3R,4S)-4-(4-chlorophenyl)pyrrolidine-3-carboxylate hydrochloride, 97.0%, 100mg

Ethyl Thiooxamate>98.0%(GC)(N)5g

(2R,3S,4R,5S,6S)-2-((5-bromo-4-chloro-1H-indol-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol, 98%, 25mg

2-Chloro-5-nitro-1H-benzo[d]imidazole, 95.0%, 1g

(R)-N,N-Dimethyl-1-(morpholin-2-yl)methanamine, 95+%, 250mg

N-(4-Benzyloxytrityl)-N'-(2-nitrobenzenesulfonyl)-1,2-diaminoethane Resin cross-linked with 1% DVB (200-400mesh) (0.9-1.1mmol/g)1g

(5-(Hydroxymethyl)furan-2-yl)boronic acid, 95.0%, 250mg

5-chloro-3-[(2-methoxyethyl)sulfanyl]-1,2,4-thiadiazole, 95.0%, 1g

Ethyl quinoline-2-carboxylate, 95.0%, 5g

2-Bromopyrazine, 98.00%, 100g

Sal sódica de 2,6-diclorofenolindofenol, AR, ACS, 5 g, envase de vidrio

4-(4'-Fluorobenzyl)piperidine, 98.0%, 5g

7-BROMOIMIDAZO[1,2-A]PYRIMIDINE, 95.0%, 50mg